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Abstract  
 
Fears of cancer recurrence (FCR) in patients with breast cancer may develop during radiotherapy. 
Radiographer communication with their patients may influence early survivorship FCR level. 
 
Aim 
To investigate the management of emotional talk in patients with breast cancer attending their 
initial review appointments during radiotherapy and predict FCR at 6-8 weeks follow-up. 
 
Methods 
A mixed methods observational study was conducted.  Patients (consecutive sample, n = 60) with 
breast cancer, attending a major Scottish cancer centre, had their first two review appointments 
with their therapeutic radiographer (TR) audio-recorded. In addition, FCR was assessed (FCR7) at 
baseline and at 6-8 weeks following their final radiotherapy visit. Two TRs participated. Audio-files 
were coded by the VR-CoDES system to identify emotional cues and therapeutic radiographer (TR) 
responses. Linear regression models were tested for fit and to identify factors associated with 
follow-up FCR, i.e. patient cues, responses by TR. 
 
Results 
Follow-up FCR was predicted negatively (robust estimator, p = .01) by level of patient emotional talk 
at the second review session.  The provision of space by the TR, at the second session, to enable 
patients to expand their emotional utterances was also associated, but negatively (p = .01), with 
follow-up FCR.  These effects were maintained after inclusion of covariates: age, treatment received 
and living conditions. 
 
Conclusions 
Patient’s emotional expression and TR responses at the second review meeting predicted follow-up 
FCR.  The study shows the effect of communication processes on this specific distress component of 
the patient's survivorship experience.   
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Patients with breast cancer may experience distress in the form of fears of cancer recurrence (FCR) 
during their recovery from primary treatment [6].  The proportion who report moderate to severe 
FCR varies from 30 to 70% [23]. These levels are unpleasant for patients, and have negative 
consequences including propensity to depression, sleeplessness, reduced quality of life, requests for 
more checks and increased health service utilisation [18]. One report has shown that FCR may be 
present as early as the diagnostic stage of cancer [12].  Systematic review methodology has shown 
that treatments, such as chemotherapy [31] and radiotherapy [30], on average, have been 
associated significantly with FCR increases.  Admittedly, correlational investigations are of limited 
value especially with high heterogeneity in time locations of FCR assessments. However the psycho-
oncology literature has recognised that the way clinicians communicate to their patients is a vital aid 
to patient recovery [7].  A detailed model has been developed to assist researchers investigate these 
processes [26].  Our research focus is radiotherapy treatment [28].  This complex and technically 
demanding intervention requires substantial resources from the health care providers including the 
patient, e.g. multiple regular visits requiring frequent travel.  It is also, very often, the final 
recommended treatment prior to discharge and patients may remember clearly how staff managed 
them. 
 
The field of health care communication is advancing in oncology with many recommendations for 
good practice and training programmes [13].  In summary, the clinician is expected to deliver 
comprehensible descriptions of the disease and treatment, to listen to patients’ concerns and 
acknowledge their concerns in an empathic and considerate manner. The exact combination of 
these behaviours that may be favourable will vary between clinicians, patients and the treatment 
context.  A qualitative study has reported patients’ and oncologists’ preferences on how to approach 
emotional talk [29].  Direct observations, however, may further assist our understanding.   Research 
tools are available to test best evidence for clinicians to ease treatment acceptability and manage 
patient distress. One tool is the VR-CoDES system for coding emotional concerns and cues [4, 32]. 
We have reported on the sequence of emotional cues that patients express and the type of response 
from Therapeutic Radiographers [16].  In addition, in a mixed-methods study we found that the 
expression of certain emotional content was linked to the FCR trajectory over radiotherapy 
treatment using a daily diary record [1].  Our interest was to explore the specific effects of patients 
raising emotional issues in appointments with their TR during their treatment.  Furthermore, how 
TRs responded to this emotional content raised by patients might have an influence on FCR 
development. For example, the patient who expresses some form of distress about their experience 
of a symptom indicator (e.g. skin inflammation) may react negatively to the TR who distracts them, 
or moves immediately onto another issue, such as medication.  The TR who enables the patient to 
expand or 'provide space' to talk through their concern might confer a lasting psychological benefit 
and prevent the patient dwelling or ruminating about the topic [5].  The manner of how these 
processes may influence outcomes have been outlined [9]. In summary, the patient who is enabled 
to express distressing content in their review consultation by the clinician may assist the patient in 
their regulation of emotional processing in the brain.  The adoption of such a self-regulation model 
has been presented in the FCR field. [19]  Our choice of outcome was FCR some weeks following 
treatment when patients had a period of time to recover and adapt to a life without intensive 
treatment, sometimes referred to as 'early survivorship' [2]. Previous research is lacking on 
predicting distress following diagnosis [3] and has tended to concentrate on baseline variables such 
as clinical and socio-economic factors.  Very few studies have focused on how patients are managed 
and their anxieties recognised or acknowledged during treatment. Hence the focus of our research is 
to investigate an aspect of this patient management and establish if there is a link between the 
communication of TR and patient, during the radiotherapy treatment phase, and FCR approximately 




To investigate the management of emotional talk in patients with breast cancer attending their 
initial review appointments during radiotherapy and assess the influence on fears of recurrence at 6-
8 weeks follow-up from end of treatment.  Our objectives were to test the effects on follow-up FCR 
of:  (1) patients disclosing emotional cues in routine review appointments, and (2) clinicians 






Consecutive patients attending the specialist cancer unit in a major hospital in Scotland were 
recruited over January to May 2016. Psychiatric disorder, non-English speaking, metastatic disease 
or consultant withdrawal were exclusion variables. Detailed sampling has been reported elsewhere 
[1]. See Appendix 1 for flow chart. Two TRs were recruited from the cancer unit. They had no prior 
training in the management of FCR. 
 
Design 
A consecutive mixed-methods approach was employed [17]. That is, self-report ratings of FCR were 
collected at baseline and at 6-8 weeks follow-up from radiotherapy treatment discharge. Codes of 
patient emotional talk and TR immediate responses were applied to the digital audio files of the first 
two review appointments. Hence, this was an observational study without randomisation. 
 
Measures 
A study-specific demographic self-report questionnaire was administered to participants to assess: 
age in years, treatment regimen (regular vs +/- boost,  i.e. regular treatment is 15 sessions, whereas, 
boost is given for positive margins and under 50 years of age), received chemotherapy or not, living 
alone vs living with others. Fears of cancer recurrence were assessed using the FCR7 which has been 
previously used with patients with breast, colorectal or head/neck cancer [15].  Reliability is good 
(Cronbach's alpha in reference breast cancer group: 0.92), and there is evidence of validity.  
 
The emotional content of the patient’s interaction with the TR was assessed using the Verona CoDES 
system that recognises emotional 'hints' or cues including frankly expressed concerns of the patient. 
The system has been endorsed by over 60 scientific articles since publication of manuals in 2011 [5].  
Specifically, the coding of the audio files was performed by one of the authors (LB) under the 
supervision of the study PI who is one of the VR-CoDES originators. The system comprises of two 
major components. First, the identification of all emotional concerns or more subtle hints, referred 
to as cues in the consultation.  Second, the immediate response in the next utterance by the health 
provider.  The cues are classified into 7 defined meaningful categories (CueA to CueG) and the 
responses by the TR are split into two major types, namely: ‘providing space’ or ‘reducing space’.  In 
other words the TR could deliver a response to the patient to provide more detail through remaining 
silent, or inviting and encouraging the patient to expand their comments, or alternatively reduce 
space for the patient to elaborate by use of distraction, changing topic or blocking [20]. The 
distinction is important as the relatively rare occasions where reducing space has been identified 
following cancer treatment is associated with subsequent mental distress. [8, 22] Coder training 
consisted of detailed reading of the coding manual and completion of the on-line exercise material 
available. In addition, the first five consultations were double coded and discrepancies discussed 
with GH and precision enhanced.  When certain utterances were highlighted by the coder as being 
difficult to identify the following procedure was followed.  Consensus was achieved after detailed 
discussion concentrating, first on the list of extensive examples supplied within the manual, and 
second, an inspection of the current context of the consultation topic.  A reliability check of eight 
randomly chosen audio files was completed by two researchers and achieved a kappa of 0.85 (95% 
CI = 0.84, 0.86), Spearman's Rho = 0.96 [11]. 
 
Procedure  
The Research Assistant (YY) approached all potential participants and invited written consent 
following reading of the patient information sheet a minimum of 24 hours prior to cancer centre 
attendance.  The baseline questionnaire was administered prior to first radiotherapy treatment and 
review appointment with their TR.  The review appointments were digitally recorded within the 
clinical setting with an unobtrusive digital studio-quality recorder with SD card unit storage that was 
transferred on the same day of recording to the 'safe haven' constructed at the Medical School for 
confidential storage on a non-networked PC.  The audio files were transformed by a propriety 
software package to be imported into the event logging software Observer XT™v12 for VR-CoDES 
coding.  The eventual files were exported into an Excel spreadsheet with identifiers removed.  The 
TRs were instructed to conduct their review sessions as usual.  If the TR became aware of a highly 
distressed patient then this individual was referred to the centre’s psychological services as per 
usual protocol of the cancer centre. 
The study was approved by East of Scotland Research Ethics Service (NRES reference number: 
13/ES/0015) and registered with ClinicalTrials.gov, ID number:  NCT02599506. 
 
Statistical analysis 
Linear regression with a robust maximum likelihood estimator (STATA™v15) was applied [25].  After 
controlling for baseline FCR (R2 of 0.38 obtained from previous study [14]) with four test and four 
further control covariates, the sample size required to detect a 0.1 R2 increase was 56 (power 
squared routine [25]).  Two nested models were fitted to explain the dependent variable: FCR at 
follow up, controlling for baseline FCR level. The first tested simultaneously the effects of number of 
cues in the two consecutive sessions and the frequency that patients were not provided space to 
expand on these emotional cues.  The second model added control covariates, namely: age in years, 
treatment regimen (regular vs boost), received chemotherapy or not, living alone vs living with 
others such as partner or spouse, to determine if the model one effects were maintained.  A 




The demographic breakdown, clinical intervention and mode of radiotherapy treatment are 
presented for the sample (Table 1).  The mean total number of cues and concerns identified per 
patient was about 20.  The mean number of cues and concerns for each consultation (first and 
second) and the frequency of reducing space when this emotional talk was coded was calculated 
(Table 1).  The TR reduced space following an instance of emotional talk on about 9% of occasions.  
Appendix 2 shows examples of patient emotional talk and provider responses.  Drop-out analysis of 
those patients without complete data on the demographic, and treatment variables compared with 
those entered into the regression revealed no differences (p > 0.05). The nearest discrepancy was 
the proportion who received chemotherapy.  Patients who were not followed tended to be less 
likely to have received this additional treatment (Χ2(1) = 2.45, p = 0.12). 
 
Follow-up FCR7 was regressed on baseline FCR7 and explained 47% of the variance. Appendix 3 
shows the raw correlation matrix.  The a priori linear model demonstrated reasonable fit (Model 1) 
with the raw data (R2 = 0.54; F = 35.45; df5, 54; p < 0.001).  The number of cues and the frequency of 
reducing space by the health provider in the second consultation were associated with the 
dependent variable (both p levels < 0.05, Table 2).  Model 2 included additional covariates to adjust 
for potential bias and explained approximately 2 percent extra variance of follow-up FCR. The 
likelihood ratio (LR) test showed that there was no improvement in Model 1 variance explained by 
the additional four covariates, i.e. Model 1 nested in Model 2; Χ2(4) = 2.15, p > 0.7.   
 
A supplementary set of models was run that included not only the number of emotional hints (i.e. 
cues) but also the less frequent concerns.  These regressions varied very little and failed to improve 
dependent variable explanation.  Furthermore, separate models of first and second consultation 
variables were fitted and gave similar p levels.  The addition of the TR identity into all regression 
models revealed trivial explanation of FRC follow-up values and communication behaviour. 
  
Discussion 
The main overall aim of the study was achieved by collecting a substantial set of 120 consultation 
recordings for detailed coding with accompanying patient completed FCR ratings and background 
variables.  The first objective was to describe the level of emotional talk in both of the review 
appointments with the patient's TR.  The level of cues and concerns identified was relatively high 
compared with other samples of patients with cancer, especially when the length of the 
appointments was no greater than 15 minutes. [10]  For example, in a study of follow-up 
appointments with the oncologist and adolescent patients the average number of cues and concerns 
expressed was 3.6 per consultation that averaged 24 minutes in duration. [21]  The association of 
cues, in the current study, with the follow-up FCR rating was positive and significant for the second 
session only. The strength of the effect was within the a priori significance level.  
The second related objective was to examine the aggregate responses by the TR to patient 
emotional talk exhibited in both sessions and inspect the association with follow-up FCR.  Again this 
association was significant only for the second session but negative.  Hence, the first session 
expression of emotions and their management by the TRs was not important in understanding the 
patients' FCR level at follow up.  
The introduction of the number of concerns, as part of the emotional talk identified,  into the 
analysis did not improve explanation, hence we excluded the addition of concerns into the 
emotional talk quotients and simply used the number of cues (for both sessions).  This selection, 
admittedly post hoc, could be of theoretical significance.  Paradoxically, it may be the somewhat 
more hidden emotional issues that are embedded in the interactions with patients undergoing 
radiotherapy that may be the most important for the TR to recognise.  Therefore, it is not simply the 
most obviously signalled concerns ("I am worried the treatment isn’t working") that are relatively 
easy to recognise by the health provider that need appropriate responses, but rather the more 
subtle indicators of emotion, e.g. “I am wondering what these ‘electric’ twitches I feel now really 
mean”.  Likewise the frequency of closing down of patients was relatively low (9% of all TR 
responses) but potentially important.  This phenomena has been identified as a critical moment in 
many clinical interviews. [5]  Patients’ presentation of emotional speech following the first session 
review meeting, that is during the second and subsequent sessions, may be especially sensitive to 
being closed down by the TR. As raised previously in the literature, once baseline distress levels are 
controlled for, additional predictors of distress outcomes are often ‘masked’ out [3].  Our data would 
partially support this, except we have identified some processes occurring during treatment to relate 
to follow-up FCR.  The importance of the patient cues presented and TR closing down on occasion at 
the second review appointment may be interpreted as follows.  The initial review may be simply 
functioning as an information exchange, and emotional expression may assume little significance. 
The second appointment however, after the patient has received some active radiotherapy 
treatment, experienced some side-effects and have the desire to share their anxieties.  These 
anxieties, if not expanded upon or shared with the current health care provider , may suppress these 
potential concerns and generate ruminative processes responsible for FCR development [19].  A 
recent article that is consistent with this formulation has demonstrated the process of patients 
experiencing ‘symptoms’ potentially triggering FCR development and consequent behavioural 
responses [24].  An accessible model that links these events to FCR has been explicated by Lee-Jones 
et al. [19] It states that certain antecedents in a cognitive-behavioural framework operate to raise 
FCR which can be reinforced through positive or negative consequences. The attendance by the 
patient to their radiotherapy treatment session may sensitize these patients and raise associated 
anxiety about cancer risk, success of treatment and possible recurrence.  The experience of the 
patient who expresses these cues or concerns and then not have them attended to by the clinician, 
may as a consequence, reinforce psychological avoidance by the patient to subsume the emotional 
experience.  Alternatively, the experience may simply provide an indicator to the patient that these 
issues are not regarded as important and are better discarded if possible. The longer term 
psychological consequence of these processes, according to the illness representation model of Lee-
Jones et al. is an exacerbation of FCR.  The clinical implication of this study would be for therapeutic 
radiographers to enable their patients to express their concerns whether they are specific to 
experienced symptoms and side effects, or considerations of cancer recurring. 
 
Limitations 
A modest sample size restricted our ability to test the expression of specific types of emotional cue 
on FCR development.  It would have been interesting to be guided as to whether, for example, the 
expressed hints to an emotion were focused on issues about external stresses outside the clinic 
environment (i.e. CueD in the VR-CoDES system).  Two members of the therapeutic radiographer 
staff participated, hence it is recognised that this cannot be generalised across radiography services.  
The baseline FCR assessment was conducted prior to the initial consultation by the TR and the first 
radiotherapy treatment session in an attempt to standardise the measurement process. All other 
ratings were assessed after the review appointments lending a possible complexity to interpretation.  
We conducted some checks for representativeness of the patient sample and showed that the 
participants retained are not substantially different from the total collected, however the baseline 
variables were not comprehensive and there is still potential for systematic bias. Furthermore, we 
expected patients to have no further treatment from the cancer centre following their final 
radiotherapy session.  They may have been in contact with the centre for advice but this was not 
recorded.  Replication is advisable and these results should be treated with caution. Future work 
should include a more comprehensive inclusion of both patients and staff, include additional 
potential confounds including: severity of illness and staff variables such as seniority and level of 
training.  In addition, we concentrated on the first two review consultations and there is scope to 





The management of emotional talk in patients with breast cancer during their early weekly review 
appointments with their TR predicts eventual FCR level some 6-8 weeks post discharge from primary 
treatment.  Additional training to increase awareness of these features on the consultations of these 
patients may be of benefit.  Studies need to be conducted to examine the generalisability of these 
findings and pinpoint whether there are particular emotional issues that may warrant close 
attention to prevent the development of disabling FCR levels.  A new study protocol to develop a 
training programme for TRs has been reported.[27] 
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Table 1  Descriptive aggregate data for variables in statistical models (1 and 2) 
Variables Mean Std. Deviation Range: min-max 
FCR7 Follow-up 14.88 8.61 6 – 40  
FCR7 Baseline 17.21 7.52 6 - 39 
Number of pt. cues: Session 1 5.33 7.89 0 - 43 
Number of pt. cues: Session 2 5.03 6.42 0 - 23 
Reducing space TR responses: Session1 0.63 0.88 0 - 3 
Reducing space TR responses: Session2 1.08 1.47 0 - 7 
Patient age (in years) 57.92 11.26 35 – 85  
    
Radiotherapy    
      Regular † 44 (73%)  
      Regular + Boost 16 (27%)  
   
Treatment received    
      No chemotherapy † 29 (48%)  
      Chemotherapy 31 (52%)  
   
Social living condition    
      With another † 48 (80%)  
      Alone 12 (20%)  
† Reference category (0) in dummy variable assignment 
 
  
Table 2 Multiple linear regression (robust estimator) to predict Follow-up FCR7 
     Model 1     Model 2 
  Beta 95% CI p Beta 95% CI p 
 FCR7 Baseline 0.716 0.48, 0.94 0.0001 0.685 0.47, 0.89 0.0001 
Session 1 Cues 0.106 -0.11, 0.12 0.32 0.047 -0.19, 0.28 0.69 
 Reduce space 0.749 -1.25, 2.74 0.46 1.053 -1.06, 3.16 0.32 
Session 2 Cues -0.514 -0.90, -0.12 0.011 -0.468 -0.91, -0.03 0.037 
 Reduce Space 1.934 0.45, 3.41 0.011 1.994 0.48, 3.51 0.011 
        
 Age    0.046 -0.15, 0.24 0.64 
 Chemotherapy †    -2.447 -6.26, 1.37 0.20 
 Treatment †    -0.256 -5.75, 5.24 0.93 
 Live alone †    0.912 -3.33, 5.16 0.63 
 Constant 1.814 -1.81, 5.52 0.33 3.06 -9.77, 15.9 0.63 
       
 R2 0.54           0.56  
 LR test    Χ2 (4) = 2.15 0.71 
FCR7   Fears of Cancer Recurrence 7-item scale 
† Specified as dummy variable 0,1 (see Table 1) 
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Breast cancer patients seen after CT scan   (N= 202 )  
Non - participation   (n= 93 )  
Reasons:   
· too busy   (n= 8 )  
· Absence of FoR (n= 6 )  
· Not wanting to be reminded of  
cancer (n= 58 )  
· Not interested (n= 18 )  
· Other health problems (n= 3 )  
Agreed to participate   (n= 109 )  
Withdrawal   before baseline  
assessment   (n= 12 )  
Reasons   
· unknown (n= 8 )  
· high levels of psychological stress (n= 3 )  
· health problems (n= 1 )    
  
  
  Completed baseline   assessment   (n= 97 )  
Withdrawal   after baseline  
assessment   (n= 3 )  
Reasons   
· feel  too negative   (n= 2 )  
· feel too boring to  complete  
questionnaires   (n= 1 )  
Entered longitudinal measurement   (n= 94)  
Did not complete post - 
treatment assessment   (n= 2)  
Completed  longitudinal measure ment   (n= 92 )  
Did not complete follow - up  
assessment   (n= 12) after 3  
phone - call attempts   
Complet ed 6 - 8 weeks follow - up  assessment   (n=  80 )  
Audio files: Session1 (n=12), Session 2 (n=3) & 
both sessions (n=5) not recorded) 
Final Sample with complete Session 1 and 2 audio files (n=60) 
 Appendix 2  Examples of Patient Utterances and Provider Responses (Using VR-
CoDES System) 
 
Patient Utterances  




Concern "I'm terrified; what kind of scan this is" 5 2 
"But it's him I'm more concerned about, I'm not interested in myself" 6 1 
"I hate being ill! I'm not a person that likes being ill" 6 2 
"I feel very stressed out and depressed and worried" 23 1 
Cue A "It’s just been a bit full on" 97 1 
"It’s getting to the stage where don-, I honestly don't think I can do it 
much longer" 
9 2 
“...if I feel a bit uuohh" 72 1 
Cue B “It feels like a needle is pinning me” 58 2 
''What's the point of taking an antidepressant?!'' 38 2 
"The chemo was for me the killer" 26 1 
Cue C ''Last night I had very little sleep…, so today I'm tired'' 32 2 
"Most of my pain, in fact probably all of my pain is coming from the 
fissure" 
17 2 
"Man, I woke up with a massive hot flush" 1 1 
Cue D "We haven't told the boys because we thought we were going to have 
to cancel everything when I got diagnosed" 
94 2 
"My husband's not well, and he won't take responsibility but, he's 
never come with me to an appointment" 
9 2 
"I try not to bother my younger sister, she's seven years younger than 
me, because she's recovering from cancer and she doesn't keep very 
well" 
23 1 
Cue E “It's only when I've had the radio that it does it”; “And it only happens 
when I've had the radio" 
49 2 
"What should I look out for?"; "It’s just nice to sort of know what to 
look out for" 
24 1 
"Apart from the... time for the bus again!"; "Just...come in...get off, 
get on, go!" 
2 1 
"Feel slightly more tired on a Monday"; "I was probably a wee bit 
more tired Monday" 
83 2 
Cue F Inapplicable to audiotapes - - 
Cue G "I was more angry..." 47 1 
"I was really, really frightened" 19 1 
"Panicky, like a panic attack...anxious, anxiety, erm, lack of 
confidence" 
32 1 




Provider Responses (CD=Closing Down; PS=Providing Space; Pat=Patient; Prov=Provider) 




Ignore (CD) Pat: "Yes yes, struggling a bit this week"; Prov: “How are you 
getting on with your tamoxifen, are you having any more 
problems with bruising?” 
97 1 





Pat: ”Sorry for…”; Prov: “No, don’t apologise!” 34 2 
Pat: "...no, I'm getting worried"; Prov: ”Noo, not at all!” 89 2 
Acknowledgem
ent (PS) 
Pat: "I'm trying to figure out what normal is!"; Prov: “I know, 
uhuh, mhm” 
1 1 
Pat: "I was really, really frightened"; Prov: “Were you, oh dear” 19 1 
Implicit 
Empathy (PS) 
Pat: "I didn't expect this on top of it, because it’s not connected 
seemingly... it’s not connected"; Prov: “I know, it’s a lot. A lot for 
you to get your head round” 
72 1 
Pat: "I just feel so tired"; Prov: “Sounds like you’ve been fighting 




Pat: "I'm still sore inside eh, it’s quite jagged and sore"; Prov: 
“Are you getting sharp shooting pains?” 
14 1 
Pat: "I, I go to bed and I go to sleep, but I do waken up"; Prov: 
“Right, so a bit more disturbed?” 
19 2 
Pat: "And it just suddenly hits you, this kind of overwhelming 
tiredness"; Prov: “Yeah, and are you sleeping alright?” 
15 2 
Pat: "Under my arm’s been a bit sore...a bit kinda niggly... 
inside...inside kinda niggly feeling, I don't know...”; Prov: “Sort of 
sharp shooting pains? Or just more a kind of pulling sensation?” 
90 2 
Pat: "Maybe the co-codamol has worn off, I've got to put my 
other foot forward, because to put my full weight on it, it’s 





Pat: "my biggest concern is getting here and parking and, and, 





Pat: "I've never felt as emotionally raw"; Prov: “How did you feel 
after you were told that you’d had the cancer diagnosed, did you 




Pat: "You think for God's sake how did this happen"; Prov: “I 
think that’s hard to deal with when you’re doing all you can to 
keep yourself healthy” 
97 2 
Pat: "I said I felt very lonely... I feel like everything's my 
responsibility, I'm the only one that's working"; Prov: “And that’s 
very very hard when you’re the one that’s needing some support 
and attention yourself” 
9 1 
 
Appendix  3 Pearson Correlation Matrix  
 Variable 1 2 3 4 5 6 7 8 9 
1 FCR7 Follow-up 1.000         
2 FCR7 Baseline 0.686 1.000        
3 No. of pt. cues: Session 1 0.303 0.351 1.000       
4 No. of pt. cues: Session 2 0.005 0.071 0.415 1.000      
5 Reducing space TR responses: Session 1 0.271 0.237 0.385 0.318 1.000     
6 Reducing space TR responses: Session 2 0.205 0.105 0.318 0.727 0.362 1.000    
7 Age (in years) -0.134 -0.190 0.114 -0.047 0.065 -0.175 1.000   
8 Treatment received † -0.291 -0.298 -0.122 0.105 0.166 0.078 0.390 1.000  
9 Social Living conditions † 0.163 0.120 0.160 -0.117 0.019 0.000 0.037 -0.017 1.000 
10 Radiotherapy † 0.114 0.190 -0.022 0.177 -0.006 0.249 -0.515 -0.096 0.075 
  † See Dummy variable key in Table 1         
